| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $144.6M | -68.7% |
| Cost of Revenue | $155.6M | -66.0% |
| Gross Profit | -$11.1M | -401.7% |
| R&D Expense | $51.3M | -9.2% |
| SG&A Expense | $88.1M | +17.6% |
| Operating Income | -$839.5M | -368.1% |
| Pre-tax Income | -$853.7M | -509.9% |
| Income Tax | $332K | -23.3% |
| Net Income | -$854.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.3M | -46.6% |
| Accounts Receivable | $59.3M | -80.4% |
| Inventory | $10.9M | -59.0% |
| Current Assets | $136.6M | -71.1% |
| Total Assets | $437.4M | -67.8% |
| Current Liabilities | $128.8M | -48.7% |
| Total Liabilities | $835.2M | -10.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.6M | +82.3% |
| Investing Cash Flow | -$3.5M | -102.6% |
| Financing Cash Flow | -$8.4M | -109.4% |
| -508.2% |
| EPS (Basic) | -$5.29 | -487.8% |
| EPS (Diluted) | -$5.29 | -487.8% |
| Stockholders' Equity |
| -$398.4M |
| -193.5% |